FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+20.9%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$38.4B
AUM Growth
+$3.99B
(+12%)
Cap. Flow
-$616M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
28.98%
Holding
520
New
61
Increased
186
Reduced
165
Closed
55
Top Buys
| 1 |
CME Group
CME
|
$217M |
| 2 |
Qualcomm
QCOM
|
$199M |
| 3 |
Appian
APPN
|
$180M |
| 4 |
DraftKings
DKNG
|
$173M |
| 5 |
Advanced Micro Devices
AMD
|
$170M |
Top Sells
| 1 |
Alibaba
BABA
|
$445M |
| 2 |
Boston Scientific
BSX
|
$340M |
| 3 |
Fidelity National Information Services
FIS
|
$297M |
| 4 |
Intercontinental Exchange
ICE
|
$229M |
| 5 |
Crown Castle
CCI
|
$210M |
Sector Composition
| 1 | Technology | 35.81% |
| 2 | Healthcare | 20.96% |
| 3 | Consumer Discretionary | 14.53% |
| 4 | Communication Services | 9.02% |
| 5 | Financials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Fate Therapeutics
FATE
$116M
| $1.35M | ﹤0.01% |
14,837
-13,326
| -47% | -$1.21M |
|
352
Lamar Advertising Co
LAMR
$13B
| $1.34M | ﹤0.01% |
16,046
| – | – |
|
|
CNST
353
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $1.32M | ﹤0.01% |
45,811
-32,373
| -41% | -$932K |
|
354
Welltower
WELL
$112B
| $1.29M | ﹤0.01% |
19,904
| – | – |
|
355
New Oriental
EDU
$7.98B
| $1.21M | ﹤0.01% |
6,500
-2,700
| -29% | -$502K |
|
356
TotalEnergies
TTE
$133B
| $1.21M | ﹤0.01% |
28,832
+8,942
| +45% | +$375K |
|
357
Axsome Therapeutics
AXSM
$6.25B
| $1.2M | ﹤0.01% |
14,670
-331
| -2% | -$27K |
|
358
Novartis
NVS
$251B
| $1.19M | ﹤0.01% |
12,635
-13,067
| -51% | -$1.23M |
|
359
Garmin
GRMN
$45.7B
| $1.17M | ﹤0.01% |
9,799
| – | – |
|
360
iShares Russell 2000 Growth ETF
IWO
$12.5B
| $1.15M | ﹤0.01% |
4,016
+3,202
| +393% | +$918K |
|
361
Equinix
EQIX
$75.7B
| $1.12M | ﹤0.01% |
1,568
+1
| +0.1% | +$714 |
|
362
StoneCo
STNE
$4.63B
| $1.12M | ﹤0.01% |
13,294
-7,206
| -35% | -$605K |
|
363
Carlyle Group
CG
$23.1B
| $1.11M | ﹤0.01% |
35,417
| – | – |
|
|
ONC
364
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $1.11M | ﹤0.01% |
4,293
-97
| -2% | -$25.1K |
|
365
Americold
COLD
$3.98B
| $1.09M | ﹤0.01% |
29,131
| – | – |
|
366
GSK
GSK
$81.6B
| $1.08M | ﹤0.01% |
23,466
| – | – |
|
|
CONE
367
DELISTED
CyrusOne Inc Common Stock
CONE
| $1.08M | ﹤0.01% |
14,754
| – | – |
|
368
Sempra
SRE
$52.9B
| $1.03M | ﹤0.01% |
16,180
+6
| +0% | +$382 |
|
369
BioLife Solutions
BLFS
$1.27B
| $1M | ﹤0.01% |
+25,146
| New | +$1M |
|
|
RETA
370
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $992K | ﹤0.01% |
8,028
-181
| -2% | -$22.4K |
|
371
Biogen
BIIB
$20.6B
| $969K | ﹤0.01% |
3,959
+3,942
| +23,188% | +$965K |
|
372
Johnson Controls International
JCI
$69.5B
| $967K | ﹤0.01% |
20,761
| – | – |
|
373
General Dynamics
GD
$86.8B
| $936K | ﹤0.01% |
6,290
| – | – |
|
374
Cheniere Energy
CQP
$26.1B
| $931K | ﹤0.01% |
26,416
| – | – |
|
|
XLRN
375
DELISTED
Acceleron Pharma Inc.
XLRN
| $907K | ﹤0.01% |
7,091
-160
| -2% | -$20.5K |
|